Michal Juraska

15PUBLICATIONS
114CO-AUTHORS
Nanotoxicology, health and safetyEpidemiological methodsMedical biotechnology diagnostics (incl. biosensors)Molecular evolutionGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Sep 15, 2026
Comparing Approaches for Estimating Counterfactual HIV Incidence Among Populations With High Vulnerability to HIV in Lima, Peru: A Multi-Study Comparative Analysis.

|Sep 08, 2026
VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

|May 25, 2026
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Jun 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development.

Peter B Gilbert, James Peng, Larry Han

Pageof 3

Frequent Collaborators

12 joint publications

Lawrence Corey

11 joint publications

Peter Gilbert

9 joint publications

Craig Magaret

8 joint publications

Lindsay N Carpp